PMC:7170368 / 3049-5083
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 144 | 54-60 | Species | denotes | People | Tax:9606 |
| 145 | 137-145 | Species | denotes | patients | Tax:9606 |
| 146 | 149-157 | Species | denotes | patients | Tax:9606 |
| 147 | 248-256 | Species | denotes | patients | Tax:9606 |
| 148 | 302-308 | Species | denotes | People | Tax:9606 |
| 149 | 376-384 | Species | denotes | patients | Tax:9606 |
| 150 | 444-452 | Species | denotes | patients | Tax:9606 |
| 151 | 674-684 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 152 | 1156-1162 | Species | denotes | People | Tax:9606 |
| 153 | 1218-1226 | Species | denotes | patients | Tax:9606 |
| 154 | 1305-1311 | Species | denotes | People | Tax:9606 |
| 155 | 1482-1490 | Species | denotes | patients | Tax:9606 |
| 156 | 1617-1625 | Species | denotes | patients | Tax:9606 |
| 157 | 262-270 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 158 | 390-402 | Disease | denotes | hypertension | MESH:D006973 |
| 159 | 435-443 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 160 | 1025-1033 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 161 | 1209-1217 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 162 | 1333-1345 | Disease | denotes | Hypertension | MESH:D006973 |
| 163 | 1449-1461 | Disease | denotes | Hypertension | MESH:D006973 |
| 164 | 1469-1481 | Disease | denotes | Hypertensive | MESH:D006973 |
| 165 | 1496-1504 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T32 | 262-270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T33 | 390-402 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T34 | 435-443 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T35 | 674-682 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T36 | 1025-1033 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T37 | 1209-1217 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T38 | 1333-1345 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T39 | 1449-1461 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T40 | 1496-1504 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T22 | 188-189 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T23 | 325-327 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T24 | 587-588 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T25 | 824-825 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T26 | 1004-1007 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T27 | 1406-1410 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T28 | 1658-1660 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T29 | 1868-1872 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T30 | 1953-1959 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T31 | 1978-1982 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T47 | 627-629 | Chemical | denotes | Co | http://purl.obolibrary.org/obo/CHEBI_27638 |
| T48 | 1546-1567 | Chemical | denotes | antihypertensive drug | http://purl.obolibrary.org/obo/CHEBI_35674 |
| T49 | 1563-1567 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 0-7 | Sentence | denotes | Methods |
| T27 | 8-90 | Sentence | denotes | This study was approved by the Shenzhen Third People’s Hospital Ethical Committee. |
| T28 | 91-174 | Sentence | denotes | Verbal informed consent was obtained from all patients or patients’ family members. |
| T29 | 175-356 | Sentence | denotes | We performed a retrospective review of medical records from hospitalized patients with COVID-19 admitted to the Shenzhen Third People’s Hospital from 11 January to 23 February 2020. |
| T30 | 357-453 | Sentence | denotes | The information on patients with hypertension was extracted from all enrolled COVID-19 patients. |
| T31 | 454-586 | Sentence | denotes | We reviewed the clinical data extracted from electronic medical records, including clinical symptoms, signs and laboratory findings. |
| T32 | 587-685 | Sentence | denotes | A commercial real-time PCR kit (GeneoDX Co., Ltd., Shanghai, China) was used to detect SARS-CoV-2. |
| T33 | 686-810 | Sentence | denotes | Samples were considered positive if the cycle threshold value (Ct-value) less than 37 and negative if Ct-value more than 40. |
| T34 | 811-887 | Sentence | denotes | Samples with a Ct-value between 37 and 40 require confirmation by retesting. |
| T35 | 888-1008 | Sentence | denotes | Samples identified as positive by the local laboratory were further validated by the key laboratory of the Shenzhen CDC. |
| T36 | 1009-1183 | Sentence | denotes | The severity of COVID-19 wasidentified during the hospitalization according to the guidelines established by the National Health Commission of the People’s Republic of China. |
| T37 | 1184-1332 | Sentence | denotes | Therapeutic regimens for COVID-19 patients complied with guidelines established by the National Health Commission of the People’s Republic of China. |
| T38 | 1333-1468 | Sentence | denotes | Hypertension was classified as Grade 1, Grade 2 and Grade 3 according to 2018 guidelines of the European Society of Hypertension (ESH). |
| T39 | 1469-1579 | Sentence | denotes | Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments. |
| T40 | 1580-1661 | Sentence | denotes | Detailed information on the enrolled patients is shown in supplementary Table S1. |
| T41 | 1662-1727 | Sentence | denotes | The SPSS 18.0 software package was used for statistical analysis. |
| T42 | 1728-1873 | Sentence | denotes | Measurement data are expressed as the median and interquartile range (IQR), and the difference between groups was compared by an unpaired t test. |
| T43 | 1874-1983 | Sentence | denotes | Count data are expressed as percentages, and the difference between groups was tested by the Chi-square test. |
| T44 | 1984-2034 | Sentence | denotes | P < 0.05 was considered statistically significant. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T11 | 390-402 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T12 | 1333-1345 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T13 | 1449-1461 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T14 | 1469-1481 | Phenotype | denotes | Hypertensive | http://purl.obolibrary.org/obo/HP_0000822 |